Background: Delirium is the most common neuropsychiatric syndrome encountered by clinicians dealing with older adults and the medically ill and is best characterized by 5 core domains: cognitive deficits, attentional deficits, circadian rhythm dysregulation, emotional dysregulation, and alteration in psychomotor functioning.
| WHAT IS DELIRIUM?
Delirium is the most common neuropsychiatric syndrome encountered by clinicians dealing with older adults and the medically ill. 1, 2 Delirium is an acute or subacute disorder, usually developing within hours to days, which represents a change from the patient's baseline cognitive functioning, characterized by disturbances in attention, awareness, and multiple aspects of cognitive functioning, not better explained by a preexisting or other neurocognitive disorder. 3 The phenomenon of delirium is best understood as having 5 core domains ( Figure 1 ): cognitive deficits (characterized by perceptual distortions, impairment in memory, abstract thinking and comprehension, executive dysfunction, and disorientation); attentional deficits (characterized by disturbances in consciousness and a reduced ability to direct, focus, sustain, and shift attention); circadian rhythm dysregulation (characterized by fragmentation of the sleep-wake cycle); emotional dysregulation (characterized by perplexity, fear, anxiety, irritability, and/or anger); and psychomotor dysregulation (which confers the various phenotypic presentations).
Inflammation has long been recognized as a trigger for episodes of delirium, particularly in older adults, 22, [28] [29] [30] [31] [32] with a correlation between the severity of the patient's underlying medical problem and the development of delirium. 18, 33 The NIH proposes that peripheral inflammatory processes (eg, infections and surgery) induce activation of brain parenchymal cells, which express inflammatory cytokines and other inflammatory mediators in the CNS (eg, C-reactive protein, interleukin [IL]-6, tumor necrosis factor alpha, IL-1RA, IL-10, and IL-8), 34, 35 leading to neuronal and synaptic dysfunction and subsequent neurobehavioral and cognitive symptoms characteristic of delirium ( Figure 6 ). 31, [36] [37] [38] Studies have demonstrated that microglia can be primed by prior FIGURE 1 Delirium core domains. The phenomenon of delirium has 5 core domains: cognitive deficits (characterized by perceptual distortions, impairment in memory, abstract thinking and comprehension, executive dysfunction, and disorientation), attentional deficits (characterized by disturbances in consciousness and a reduced ability to direct, focus, sustain, and shift attention), circadian rhythm dysregulation (characterized by fragmentation of the sleep-wake cycle), emotional dysregulation (characterized by perplexity, fear, anxiety, irritability, and/or anger), and psychomotor dysregulation (which confers the various phenotypic presentations) [ the prodromal phase usually marked by restlessness, anxiety, irritability, and sleep disturbances, which usually develop over a period of hours to days; the traditional hypoactive, hyperactive, and mixed motoric types (with the extremes of catatonic retardation and catatonic excitement); and a potential chronic or persistent delirium type [Colour figure can be viewed at wileyonlinelibrary.com] 
Risk factors Examples
Electrolyte abnormalities and fluid imbalance
Electrolyte disturbances (eg, hyperammonemia, hypocalcemia/hypercalcemia, hypokalemia/hyperkalemia, hypomagnesemia/hypermagnesemia, hyponatremia/hypernatremia, hypophosphatemia/hyperphosphatemia, hypochloremia/hyperchloremia); hypovolemia (eg, dehydration, bleeding, and emesis); hypervolemia (eg, volume overload due to excessive fluid supplementation, hepatic failure, renal failure, and heart failure)
Neurological disorders and injuries All neurological disorders (eg, central nervous system [CNS] malignancies, abscesses, cerebrovascular accident, intracranial bleed, meningitis, encephalitis, neoplasms, vasculitis, multiple sclerosis, epilepsy, Parkinson disease, normal pressure hydrocephalus, traumatic brain injury, diffuse axonal injury, paraneoplastic syndrome Deficiencies (nutritional) Nutritional deficiencies (eg, malnutrition, low serum protein/albumin, low caloric intake, and "failure to thrive"), malabsorption disorders (eg, celiac disease), and hypovitaminosis, specifically deficiencies in cobalamin (B12), folate (B9), niacin (B3, leading to pellagra), thiamine (B1, leading to beriberi and Wernicke disorder)
Age and gender Age (>65) and gender (m > f). Old age is likely a contributor because of increased number of medical comorbidities; ↑ overall frailty, ↓ volume of acetylcholine-producing cells; ↓ cerebral oxidative metabolism; ↑ cognitive deficits; ↑ risk of dementia; ↑ age-related cerebral changes in stress-regulating neurotransmitters and intracellular signal transduction systems; chronic neurodegeneration with an increased production of inflammatory mediators, including cytokines and acute phase proteins
Cognitive functioning Baseline cognitive deficits, even subtle ones, have been associated with an increased risk of developing delirium. The presence of dementia, more than double the risk for postoperative delirium U-Tox or acute substance intoxication and withdrawal states Acute illicit substance intoxication (eg, cocaine, phencyclidine, lysergic acid diethylamide, and hallucinogens) and substance withdrawal states, particularly abstinence syndromes from CNS depressant agents (eg, alcohol, benzodiazepines, barbiturates, muscle relaxants, and opioids) Trauma Physical trauma and injury, heat stroke, hyperthermia and hypothermia, severe burns, surgical procedures Endocrinopathies Endocrine disturbances such as hyperthyroidism/hypothyroidism, hyperparathyroidism/hypoparathyroidism, hyperadrenalism/hypoadrenalism, exogenous corticosteroid use (eg, Cushing syndrome), hyperglycemia/ hypoglycemia, hyperpituitarism/hypopituitarism, carcinoid syndrome, porphyria
Behavioral-psychiatric disorders Certain psychiatric diagnoses, including undue emotional distress, a history of alcohol, and other substance abuse, as well as depression, schizophrenia, and bipolar disorder have been associated with a higher incidence of delirium Rx: medication use and other toxidromes Several pharmacological agents are highly deliriogenic. Among the most common agents are sedative hypnotics (eg, GABAergic agents, such as benzodiazepines, barbiturates, and propofol), anticonvulsants, anticholinergic agents, analgesics (eg, opioids, ketamine, and nonsteroidal anti-inflammatory drugs), antihistaminic agents (usually first generation and H2 blockers), antibiotics (eg, fluoroquinolones), cardiac and pulmonary agents (eg, digitalis, warfarin, sympathomimetic agents, diuretic, antiarrhythmic, and antihypertensive agents), psychotropic agents, steroids, dopamine agonists, muscle relaxant agents, immunosuppressant agents, and antiviral agents. There are a number of over-the-counter agents, especially those with anticholinergic (eg, henbane, jimson weed, datura, and mandrake) and psychoactive qualities (eg, dextromethorphan, ephedrine, and pseudoephedrine). Also must consider the toxic effects of pharmacological agents (eg, serotonin syndrome, neuroleptic malignant syndrome, and anticholinergic states) and the deleterious effects of toxic levels of various therapeutic substances (eg, lithium, tricyclic antidepressant agents, anticonvulsant agents, and immunosuppressant agents). Various toxins including carbon dioxide and monoxide poisoning, solvents, exposure to heavy metals (eg, lead, manganese, and mercury), insecticides, pesticides, poisons, and biotoxins (animal poison) can also manifest with delirium.
(Continues) The system integration failure hypothesis of delirium [Colour figure can be viewed at wileyonlinelibrary.com] Abbreviations: AA, arachidonic acid; Aβ, amyloid beta; ACh, acetylcholine; CNS, central nervous system; DA, dopamine; 5HT, 5hydroxytryptamine or serotonin; GABA, gamma-aminobutyric acid; GCs, glucocorticoids;
GLU, glutamate; IL, interleukin; NE, norepinephrine; ROS, reactive oxygen species.
neurodegenerative processes, thus triggering an exaggerated response to systemic inflammatory signals. 39, 40 See Table 4 and Figure 7 for a summary of proposed pathways by which peripheral factors elicit a neuroinflammatory response. 41 During various disease states (eg, inflammation), leukocytes adhere to the BBB endothelial cells, leading to disruption of cell-cell adhesions and increased endothelial permeability, decreased perfusion and longer diffusion distance for oxygen, 30, 42 and enhanced infiltration of leukocytes and transport of cytokines into the CNS, producing ischemia and neuronal apoptosis. 36, 43 Studies have suggested that various anesthetic agents (eg, sevoflurane and isoflurane) can cause marked disruption of BBB-associated tight junctions, leading to increased BBB permeability (Figure 8) . 44, 45 The frequency and magnitude of this effect increase with age, thus potentially serving as a mechanism to mediate POD.
| Oxidation: oxidative stress hypothesis
Mounting clinical and experimental evidence indicates that reactive oxygen species and reactive nitrogen species (eg nitric oxide, NO[*])
play important roles in many physiological and pathological conditions, 46 resulting in oxidative stress, an important mediator of damage to cell structures, including lipids and membranes, proteins, and DNA. 47 The brain is particularly susceptible because it has a large lipid content of myelin sheaths, a high rate of brain oxidative metabolism, and a low antioxidant capacity. 48 Data suggest that oxidative stress and/or antioxidant deficiencies may increase the damage to cerebral tissue, leading to cognitive decline and possibly irreversible cerebral FIGURE 5 Age and transition to delirium. This figure shows an estimation of the probability of transitioning to delirium by age and indicates that the incremental risk is large for patients 65 years and older. The probability of transitioning to delirium increased dramatically (by 2%) for each year of life after 65 years. Adjusted odds ratio, 1.01 (1.00, 1.02), P = .03. Source: Pandharipande et al 18   TABLE 3 Potential mechanisms associated with the increased risk of delirium in the elderly ○ Neuronal loss (particularly in locus coeruleus and substantia nigra.
○ Changes in various neurotransmitter systems.
○ Age-related decline in white matter integrity, observed as increases in water diffusion and volume of hyperintense white matter lesions, intergyral spans, and reduction in fractional anisotropy of water diffusion, correlated with a decline in the global and regional cerebral glucose uptake.
○ Age-related decline in regional cerebral blood flow, particularly in the anterior cingulate gyrus, bilateral basal ganglia, left prefrontal, left lateral frontal, and left superior temporal and insular cortex, as measured by single-photon emission tomography.
○ Age-related changes in cerebral blood flow, likely associated with brain microvascular pathologies
• rarefaction of the microvasculature in some regions of the brain
• decreased vascular density
• damaged microvessels, with associated microinfarcts and microhemorrhages, likely due to peripheral arterial aging leading to stiffening and dilation of the proximal aorta with transmission of flow pulsations downstream into the brain
• decline in cerebrovascular angiogenesis
• impaired cerebral blood flow due to tortuous arterioles and deposition of excessive collagen in veins and venules ○ Age-related decline in cerebral metabolic rate of oxygen more markedly in bilateral putamen, left supratemporal, left infrafrontal, and left parietal cortices.
○ Decreased oxygen supply (eg, hypoxia) leading to a decrease in redox activity, resulting in decreased acetylcholine (ACh) production (oxidative stress).
○ Decreased cerebral oxidative metabolism.
○ Age-related changes in brain neurochemical activity:
• There is a significant increase in soluble hexokinase activity with age, due to an increased release of mitochondrial-bound hexokinase.
• There is a negative correlation of the activity of fructose-6-hosphate kinase with age, particularly in the brain cortex and putamen.
• There is a significant decline of carbonic anhydrase (important in the regulation of the pO 2 /pCO 2 ratio in the brain tissue) with increasing age. Thus, pCO 2 -dependent regulation of tissue pH, ionic transport processes, and cerebral blood flow regulation have the tendency to become more and more unstable.
• There is a progressive, age-dependent decline in cyclic adenosine monophosphate-dependent activity, most significantly in the brain cortex and thalamus, followed by the hippocampus, amygdala, and globus pallidus.
○ Age-related cerebral changes in stress-regulating neurotransmitter and intracellular signal transduction systems (neurotransmitter hypothesis).
○ Decreased ACh levels in plasma and cerebrospinal fluid, which may lead to
• Decreased volume of ACh-producing cells associated with normal aging (neurotransmitter).
• Decreased ACh synthesis associated with aging.
• Increase in baseline levels of circulating inflammatory mediators including cytokines and acute phase proteins (neuroinflammation).
Source: Modified from Maldonado. 26 degeneration, potentially leading to the development of persistent delirium. 49 The oxidative stress hypothesis (OSH) suggests that delirium is ; abnormal neurotransmitter synthesis, metabolism, and release [53] [54] [55] [56] [57] ; and free radical production and a failure to effectively eliminate neurotoxic by-products. 53, 54 In fact, many have found a strong correlation between intraoperative O 2 saturation and postoperative cognitive dysfunction. 48, 58, 59 Even healthy control subjects may exhibit symptoms of delirium after experiencing a drop in their PaO 2 to 35 mm Hg. 60 Similarly, among a group of patients undergoing cardiac surgery, those who developed POD had lower preoperative and intraoperative cerebral oxygen saturation (ScO 2 ) levels, were older, and had lower preoperative hemoglobin levels compared with non-POD patients. (c) An active transport system across the blood-brain barrier (BBB) (d) A "leaky" BBB-neuroinflammation causes BBB permeability disruption, as suspected by elevations of S100 beta (a calcium-binding protein with cytokine-like properties) and changes in synaptic transmission, neural excitability, and cerebral blood flow, leading to the neurobehavioral and cognitive symptoms characteristic of delirium (eg, disruption in behavior and cognitive functions). Many of delirium's precipitant factors (eg, infections, intraoperative anesthesia, and postoperative sedation) are themselves associated with potential BBB integrity compromise. For example, it has been found that the BBB is disrupted in cases of septic encephalopathy, which allows for increased blood-brain transport of neutral amino acids.
The OSH intersects with the neurotransmitter hypothesis (NTH) 27 as decreased oxygenation causes a failure in oxidative metabolism, which leads to a failure of the adenosine triphosphatase pump system. 62 When the pump fails, the ionic gradients cannot be maintained, leading to significant influxes of sodium (Na + ) and calcium 62 In addition, at least 2 axis. [78] [79] [80] A dysregulation of the LHPA axis may lead to chronic activation of low-affinity GC receptors, which may lead to serious adverse CNS injury. 81 The hippocampus, which contains the highest concentration of GC receptors of any brain region, is a major target for the negative effects of excessive GC levels, 82 with data demonstrating that hippocampal malfunction occurs relatively early during the metabolic stress environment leading to delirium. 74, 76, 81, [83] [84] [85] [86] [87] [88] [89] The neuroendocrine hypothesis proposes that delirium represents a physiological reaction to acute or chronic stress, mediated by abnormally high GC levels. Glucocorticoids exert widespread actions in the CNS, ranging from the regulation of gene transcription, cellular signaling, modulation of synaptic structure, and transmission and glial function to behavior. 9 The neuroendocrine hypothesis proposes that, over time, repeated or prolonged high GC levels impair the ability of neurons to survive after various metabolic insults, leading to a general vulnerability in brain neurons, 83,90 also known as the "aberrant stress response." 84 There is plenty of scientific evidence demonstrating that repeated or prolonged exposure to stress and elevated GCs may have a negative impact on brain function, leading to neuronal injury and psychopathology (Figure 10 ), 9, 77 Particularly, older adults who experience POD had higher postoperative cortisol levels (P = .002) with enhanced FIGURE 9 Mechanisms of brain injury after global cerebral ischemia. During cerebral ischemia, excess glutamate exits into the extracellular compartment owing to cellular depolarization, coupled with its impaired uptake, which results in increases in intracellular Ca
2+
. The cascade of events responsible for glutamate excitotoxicity includes 3 distinct processes: (1) induction, whereby extracellular glutamate efflux is transduced by receptors on the neuronal membrane to cause intracellular Ca 2+ overload, which leads to lethal intracellular derangements; (2) amplification of the derangement, with an increase in intensity and involvement of other neurons; and (3) expression of cell death triggered by cytotoxic cascades. Excess release of Ca 2+ and its intracellular influx is thought to be the primary trigger for a variety of complex, deleterious intracellular processes that result from activation of catabolic enzymes such as phospholipases (leading to cell membrane breakdown, arachidonic acid, and free radical formation) and endonucleases (which lead to fragmentation of genomic DNA and energy failure due to mitochondrial dysfunction). Source: Harukuni and Bhardwaj 50 postoperative elevation in relation to baseline (P = .004). 15 The mechanisms linking excess GC release and neuronal injury and/or exacerbate cell death have been described elsewhere (Table 5) . 26 The loss of normal inhibition of adrenal steroidogenesis results in continuous secretion of peak amounts of corticosteroids. A relationship between dexamethasone nonsuppression and various neuropathological states has been described in dementia [91] [92] [93] and delirium. 83, [94] [95] [96] Those at higher risk for delirium (eg, older adults with baseline cognitive impairment) exhibited sustained high cortisol levels after major stressors likely due to impaired feedback regulation of the LHPA axis. 78, [96] [97] [98] [99] Cortisol nonsuppression after dexamethasone administration has been associated with delirium in 78% of subjects experiencing lower respiratory tract infection. 83 Among postoperative 100 and poststroke 95, 101 patients, increased cortisol levels and/or HPA axis dysregulation has been associated with the development of delirium. The increased GC availability associated with illness and trauma and/or exogenous steroid administration may further contribute to sustaining high levels of circulating cortisol, 102 and that may cause resistance to cortisol feedback inhibition mediated by receptor loss in the hippocampus. 75, 103 Glucocorticoids rapidly induce GLU release in the hippocampus through a mechanism that may involve a membrane-associated form of the mineralocorticoid receptor. An indirect way by which GCs can influence neurotransmission (glutamatergic, as well as GABAergic, cholinergic, noradrenergic, and
Neuroendocrine circuits in delirium. Glucocorticoids (GCs) are secreted under conditions of stress; neuronal damage and brain pathologies are a common consequence of persistently elevated GC secretion. Glucocorticoid can trigger mitochondrial dysfunction and the apoptotic machinery, as well as cell cycle arrest and cell death. In addition, stress/GC may induce neuronal atrophy and synaptic dysfunction/loss by stimulating hyperphosphorylation of the cytoskeletal protein Tau, thus disturbing the integrity of the cytoskeleton and missorting Tau at synapses. Together, these events may eventually result in the degradation of synaptic proteins and decreased synaptic plasticity. Stress and GC are also established as modulators of microglial activation and neuroinflammatory processes and may influence neuronal structure and function through epigenetic mechanisms. Source: Vyas et al 9 [Colour figure can be viewed at wileyonlinelibrary.com] Demented patients with delirium exhibited significant differences in basal cortisol levels compared with demented, nondelirious patients. Furthermore, there was a strong linear relationship between delirium and dexamethasone suppression test pathology irrespective of age and severity of dementia, that is, the greater the intensity of delirium, the greater the level of nonsuppression.
Potential mechanisms to explain how excess glucocorticoid (GC) release can compromise neuron's ability to survive neurologic insults, which may lead to or exacerbate cell death
• Inhibiting glucose transport into neuron, thus inducing metabolic vulnerability
• Increase proinflammatory cell migration, cytokine production, and even transcription factor activity in the brain
• Amplifying the damaging cascade of glutamate excess, calcium (Ca 2+ ) mobilization, and oxygen radical generation
• Inducing spine loss and dendritic atrophy, thus decreasing neuroplasticity
• Enhancing oxygen radical-mediated neurotoxicity
• Exacerbating the toxicity of other neurotoxins (eg, doxorubicin) whose mechanisms of action overlap GC pathways
• Impairing long-term potentiation (LTP)
• Reducing hippocampal glial cell activation and proliferation
• Altering the expression and signaling of neurotrophins, particularly brain-derived neurotrophic factor (BDNF)
• Exacerbating the breakdown of cytoskeletal proteins (ie, tau)
• Impairing neurogenesis Source: Modified from Maldonado.
26 serotonergic) is through cross-talk with the endocannabinoid system ( Figure 11 ). 104 Systemic corticosteroid use is a recognized risk factor for the development of delirium and other psychiatric phenomena in hospitalized patients. 15, [105] [106] [107] [108] [109] In fact, the use of exogenous steroids has been associated with the development of various neuropsychiatric disorders, including delirium, depression, mania, psychosis, and cognitive/memory impairment in up to 60% of those taking corticosteroids. 110 In older adults, systemic GC use may be a contributor to cognitive dysfunction 111 and delirium.
112,113
| Sleep: circadian rhythm dysregulation or melatonin dysregulation hypothesis
Secreted by the pineal gland, melatonin is primarily responsible for the organization of circadian rhythms, especially core temperature and sleep-wake rhythms, and multiple other physiological functions, such as immune response, antioxidative defenses, hemostasis, and glucose regulation. 114 The circadian pattern of pineal melatonin secretion is regulated by the biological clock that resides within the hypothalamic suprachiasmatic nucleus, 115 synchronized to the environmental light-dark cycle ( Figure 12 ). 116,117 Figure 13 details the relationship between inflammation and the metabolism of tryptophan, 5HT, melatonin, and kynurenic and quinolinic acid. Table 6 contains a summary of melatonin's physiological effects, which may be protective against delirium. 118 The circadian rhythm dysregulation hypothesis suggests that disruptions to the 24-hour circadian cycle, the usual stages of sleep, and variations in natural light exposure may lead to disturbances in the physiological sleep architecture that may contribute to the development of delirium. 26, 27, 119 There is evidence suggesting that chronic sleep deprivation is a physiological stressor, resulting in an allostatic load contributing to cognitive problems and delirium, likely via increased levels of proinflammatory cytokines, decreased parasympathetic and increased sympathetic tone, increased blood pressure, increased evening cortisol levels, and elevated insulin and blood glucose. 120, 121 Ongoing sleep deprivation can lead to cumulative sleep debt, which in turn, may be a contributing factor of delirium and its associated cognitive deficits. [122] [123] [124] In fact, circadian disruptions have long been recognized as a potential pathologic mechanism of the increased risk for multiple medical conditions, including delirium. 125 Sleep deprivation consistently precede the onset of delirium in postsurgical cardiac patients.
126,127
Studies have demonstrated a relationship between abnormally low melatonin serum levels and POD. 128 Similarly, ICU delirium was significantly more likely among sleep-deprived patients. 129, 130 Various studies have demonstrated a relationship between melatonin levels and delirium motoric phenotypic presentations.
Among hospitalized medically ill older adults, decreased levels of urinary 6-sulfatoxymelatonin (the chief metabolite of melatonin) were FIGURE 11 Steroid effects in neurotransmission. Glucocorticoids can bind, with different affinities, to glucocorticoid and mineralocorticoid receptors, which are expressed throughout the brain. Adrenal steroids can have both rapid and delayed effects, resulting from nongenomic mechanisms (mediated by membrane receptors), indirect genomic mechanisms (mediated by membrane receptors and second messengers) and genomic mechanisms (mediated by cytoplasmic receptors that move to the nucleus and act as transcription factors). Although mineralocorticoid and glucocorticoid receptors seem to mediate many of these effects, other membrane-associated receptors, including G protein-coupled receptors, may also be involved in some of these actions. Glucocorticoids rapidly induce glutamate release in the hippocampus through a mechanism that is absent when the mineralocorticoid receptor is deleted and that may involve a membrane-associated form of the mineralocorticoid receptor. An indirect way by which glucocorticoids can influence neurotransmission (glutamatergic, as well as GABAergic, cholinergic, noradrenergic, and serotonergic) is through crosstalk with the endocannabinoid system. They rapidly stimulate endocannabinoid production in the brain, whereupon endocannabinoids bind to cannabinoid receptor 1 (CB1) and transient receptor potential cation channel subfamily V member 1 (TRPV1) and inhibit neurotransmitter release. Although a G protein-coupled receptor is implicated in endocannabinoid production, there is also evidence for a mechanism blocked by Ru486-a selective antagonist of the classical cytoplasmic glucocorticoid receptor-in the rapid actions of glucocorticoids in prefrontal cortex. Source: McEwen et al 104 [Colour figure can be viewed at wileyonlinelibrary.com] found during periods of hyperactive delirium, while patients with hypoactive delirium had raised 6-sulfatoxymelatonin levels. 131 Studies have demonstrated that the administration of melatonin may improve the quality of sleep and prolong sleep time 132 among ICU patients, while others have found that the prophylactic administration of low-dose, exogenous melatonin may decrease the incidence of delirium. 133, 134 A meta-analysis of randomized controlled trials of studies using exogenous melatonin for delirium prevention found that melatonin supplementation had a significant preventive effect in decreasing the incidence of delirium in medically ill older adults. 135 
| CRITICAL ETIOLOGICAL FACTORS IN THE DEVELOPMENT OF DELIRIUM
The critical etiological factors in the development of delirium include the 2 proximal steps leading to the ultimate failure of system integration, and likely the factors contributing to the phenotypic presentation of delirium: an alteration in neurotransmitter synthesis, function and/or availability, and a failure in the balanced and integrated function of multiple neuronal networks that normally would work in sync to maintain adequate processing of sensory information and motor responses.
26

FIGURE 13
Metabolic pattern of tryptophan (TRP), 5-hydroxytryptamine, melatonin, and kynurenic and quinolinic acid. Evidence suggests that some proinflammatory cytokines not only can induce sickness behavior but also can enhance activity of the ubiquitous indoleamine-2,3-dioxygenase, leading to deficient TRP levels, thus a reduction in 5-hydroxytryptamine and melatonin production and a shift to the production of kynurenine and other neurotoxic TRP-derived metabolites. Source: Modified from Stone et al 118 [Colour figure can be viewed at wileyonlinelibrary.com]
Control of melatonin secretion. Photic information is conveyed to the suprachiasmatic nuclei (SCN), principally through the retinohypothalamic tract (RHT), where it synchronizes the activity of the circadian oscillator to exactly 24 h. Neuronal efferent pathways from the SCN directly distribute circadian information to different brain areas, including the pineal gland, which generates the melatonin rhythm. The generated melatonin rhythm might be used by the SCN to distribute its rhythmic information. Reprinted from Cardinali and Pevet 116
| Neurotransmission: NTH
The NTH suggests that the most commonly described neurotransmitter changes associated with delirium are reduced availability of Ach (↓Ach); excess release of DA (↑DA), NE (↑NE), and/or GLU (↑GLU); and alterations (eg, both a decreased activity and an increased activity depending on circumstances and etiological factors) in serotonin (↓↑5HT), histamine (↓↑H1&2), and/or gamma-aminobutyric acid (↓↑GABA), as previously reviewed by others (Table 7 ; Figure 10 ). 1, 26, 27, 136, 137 The NTH stresses the fact that the cholinergic and dopaminergic systems not only interact with each other also exert influence on other significant neurotransmitter systems: the glutamatergic (GLU; the primary excitatory neurotransmitter) and GABA (the primary inhibitory neurotransmitter) pathways. 138 Furthermore, some pharmacological agents (eg, opioids) may cause delirium by increasing DA and GLU activity, while decreasing ACh availability 139 or altering GABAergic ○ Reduces the affinity of glucocorticoid (GC) receptors, prevents GC inhibition of cell proliferation, and reduces the GC-induced neurotoxicity and apoptosis effects. 27 Table 8 contains a summary of the neurotransmitter alterations associated with delirium.
| Functional connectivity: network disconnectivity hypothesis
Criterion A of the DSM-5 for delirium describes it as a disturbance in attention and awareness. 3 Recent advances in diffusion-weighted magnetic resonance imaging and tractography methods have greatly facilitated the noninvasive mapping of structural networks in the human brain (see Figure 14) . 140, 141, 143, 144 The network disconnectivity hypothesis (NDH) recognizes that the brain is intrinsically organized into dynamic, anticorrelated functional networks 145 and that reduced network anticorrelation may explain the attentional deficits observed in delirious patients (see Figure 15 ). 146 Intact consciousness requires integrity of functional networks and their connectivity, based on a cooperative but mutually exclusive paradigm of introspection (ie, default mode network
[DMN]) versus external awareness (ie, task positive network).
The DMN is a group of brain regions that is preferentially more active at rest than during attention-demanding tasks and characterized by a high degree of functional connectivity. [147] [148] [149] [150] [151] Anatomically, it includes the posteromedial cortex (including the posterior cingulate cortex), the anteromedial cortex, and temporoparietal junctions. 145, [151] [152] [153] [154] The DMN in the healthy brain is associated with stimulus-independent thought and self-reflection and that greater suppression of the DMN is associated with better performance on attention-demanding tasks. 155 In contrast, the task positive network is mostly active during external focused attention and goal-directed task performance.
Anatomically, the task positive network encompasses regions of the dorsal attention system, the dorsolateral and ventrolateral prefrontal regions, the insular cortex, and the supplementary motor area and the pre-supplementary motor area. 145 The NDH suggests that the brain is a highly organized and interconnected structure functioning to allow complex integration of sensory information and motor responses and suggests that delirium represents a variable failure in the integration and appropriate processing of sensory information and motor responses. 26 Thus, the NDH proposes that delirium results from an acute breakdown in network connectivity within the brain. 156 According to the NDH, 2 important determinants predict a subject's vulnerability to delirium: (a) the baseline network connectivity (defined as the connectivity of neural networks within the brain before the precipitating insult provoking delirium), which is influenced by most recognized "nonmodifiable delirium risk factors" (eg, age and baseline level of cognitive functioning), and (b) the level of inhibitory tone, which will determine the degree of change in network connectivity and is influenced by a number of factors, including neurotransmitter functionality and availability. 156 This model suggests that these 2 determinants affect separate neuronal networks to variable degrees, thus leading to the various clinically observed deliria motoric phenotypes (eg, hyperactive, hypoactive, and mixed). The form of delirium that ensues will depend upon how and which networks break down, influenced by both the individual's baseline network connectivity and the degree change in inhibitory tone produced.
Resting state functional magnetic resonance imaging scans, obtained during and after the resolution of delirium, have demonstrated a long-lasting disruption in reciprocity of the dorsolateral prefrontal cortex with the posterior cingulate cortex and a reversible reduction of functional connectivity of subcortical regions (eg, thalamus) with the reticular activating system and with nuclei responsible for forebrain ACh (ie, the midbrain nucleus basalis) and DA innervation (ie, the midbrain ventral tegmental area). 146 The persistence of these physiological disruptions, beyond the resolution of acute delirious symptoms, may account for reported cognitive problems, which often outlast the acute episode of delirium. Electroencephalographic and evoked potential data may provide further support for this theory by suggesting that the pathophysiology of at least some forms of delirium may have a subcortical component. 157 The NDH intersects with the NTH as studies have demonstrated that some core symptoms of delirium likely involve changes in dynamic aspects of neuronal activity affecting the brain's ability to integrate information through functional disconnection between different anatomical structures 158 ; also see Figure 16 . In fact, consciousnessaltering anesthetic agents (eg, propofol, benzodiazepines, and ketamine) achieve their effect by disturbing the connectivity between brain regions composing the resting-state consciousness networks, including the DMN, executive control network, salience network, auditory network, sensorimotor network, and visual network sustain mentation. 161 Altered GABAergic neurotransmission is implicated in increasing the CNS's inhibitory tone, which may contribute to the development of delirium. 156 Furthermore, GABAergic agents may further destabilize the sleep-wake cycle, as they suppress orexinergic neural firing in the perifornical nucleus, 162 whose function is to prevent inappropriate transition into sleep. [163] [164] [165] [166] The NDH also relates to the NIH as acute neuroinflammation affects physiological processes implicated in neuronal and synaptic functions with consequent neurochemical disturbances and functional disconnection between different anatomical structures. 36 In fact, systemic inflammation drives an upregulation in expression of GABA A receptors and an increased in GABA synthesis 167 and suppresses orexinergic neuronal activity during the wakeful period.
168
This model also intersects with the neuronal aging hypothesis as it suggests that aging is accompanied by disruptive alterations in the coordination of large-scale brain systems that support high-level cognition. 156, 169 A study assessing white matter (WM) integrity using diffusion tensor imaging suggested that abnormalities in the deep WMs and thalamus could have accounted for the patients' vulnerability to developing delirium after cardiac surgery, compared with nondelirious subjects. 170 A more recent study, also conducted among older cardiac surgery patients, demonstrated that the prevalence of severe cerebral WM hyperintensities on magnetic resonance imaging was significantly higher in delirious patients and similarly concluded that these lesions were likely one of the most important risk factors for the development of delirium after cardiac surgery. 171 Finally, aging is also associated with a reduction in GABAergic tone, thus allowing for increased neuronal activity in certain brain regions, 
Acetylcholine (↓Ach)
The cholinergic system is one of the most important modulatory neurotransmitter systems in the brain, controlling activities that depend on selective attention, which themselves are an essential component of conscious awareness (the 2 key components in the criteria of Diagnostic and Statistical Manual of Mental Disorders, fifth edition, for diagnosing delirium). Adequate acetylcholine (ACh) levels are also essential for the regulation of multiple neuropsychiatric functions, including rapid eye movement sleep, memory, and synchronization of the electroencephalogram, all of which are somehow impaired in delirium. An impairment of central cholinergic transmission is often considered "a common denominator" in delirium, with multiple studies documenting low levels of ACh in plasma and cerebrospinal fluid of delirious patients. Cortical ACh deficiencies allow irrelevant intrinsic and sensory information to enter conscious awareness and may explain the impairments in cognition, attention, emotional dysregulation, and disturbance in circadian rhythm at the core of delirium. Finally, high levels for serum anticholinergic activity (SAA) have been associated with an increased likelihood of delirium among medically ill patients as well as in postoperative delirium (POD), consistent with the clinical relationship observed between a drug's anticholinergic potential and its deliriogenic effects. Evidence suggests that an elevation in SAA levels predicts the development of delirium, while a resolving delirium is correlated to normalizing SAA levels. It also explains why the use of physostigmine, a reversible cholinesterase inhibitor, is effective in reversing the prolonged coma, myoclonus, and delirium induced by anticholinergic drugs. Dopamine-mediated potentiation of glutamate (GLU)-mediated exocytotic injury, and/or induction of apoptosis by mechanisms independent of oxidative stress, which may explain why DA depletion by alpha-methyl-paratyrosine may have a neuroprotective effect against hypoxic stress and injury and why DA blockade can be used to reduce hypoxic damage in the hippocampus. Data suggest that DA administration is associated with nearly a tripling of the odds of the subsequent need of the antipsychotic drug for management of delirium and associated behavioral disturbance. Others have found both DA administration (P < .001) and the amount of DA administered (P < .001) as independent risk factors for delirium along with older age (P = .03). It is also important to note the growing body of evidence demonstrating that antipsychotic agents are effective not only as treatment of delirium, in delirium prevention. Studies have revealed that there are no significant differences in efficacy among antipsychotic agents, with no major differences in response rates between clinical subtypes of delirium. Thus, it is possible that not only are antipsychotic agents effective in the symptomatic management of the symptoms of delirium, but they also address the underlying massive DA surge associated with all delirial phenotypes, even the hypoactive type.
Norepinephrine (↑NE) Excess norepinephrine (NE) release secondary to hypoxia or ischemia leads to further neuronal injury and the development or worsening of delirium. Delirium has long been speculated to be associated with excess release of NE. Studies have found that increased epinephrine and NE urinary levels predicted the incidence of delirium among hospitalized, older patients. Specifically, in cases of alcohol withdrawal syndromes (AWSs), excess noradrenergic activity drives most of the symptoms (eg, diaphoresis, tachycardia, increased blood pressure, restlessness, anxiety, agitation, and tremors). Upon abrupt cessation of alcohol consumption, there is evidence of decreased signaling at the α 2 receptor, resulting in an inability of the noradrenergic system to regulate its firing leading to AWS. In addition, alcohol withdrawal causes an upregulation of glutamate transmission in the locus coeruleus (the major noradrenergic nucleus of the brain), increasing the activity of the noradrenergic system. This may contribute to the autonomic instability, behavioral agitation, and psychosis seen during alcohol withdrawal delirium or delirium tremens. Furthermore, catecholamines can enhance the activity of the bed nucleus of the stria terminalis neurons, which may, in turn, increase the excitability of glutamatergic bed nucleus of the stria terminalis neurons that project to the ventral tegmental area. In fact, there is evidence of a normalization in plasma concentration of epinephrine as AWS improved. Randomized clinical trials have demonstrated that selective alpha-2 agonist agents (eg, dexmedetomidine [DEX]) substantially decreased the incidence of POD compared with GABAergic agents, particularly among older people; decreased incidence of delirium tremens upon alcohol cessation; shorter mechanical ventilation times; and reduced the incidence of emergence delirium. Similarly, alpha-2 agonist agents have shown neuroprotective qualities by suppressing circulating catecholamine levels during cerebral ischemia. Some have found that DEX-based sedation is associated with a lower risk of neurocognitive dysfunction and is associated with improved sleep quality in elderly intensive care unit patients, while others have found that the use of DEX may decrease neuroinflammation via inhibition in the expression of monocyte chemoattractant protein 1 messenger RNA (P < 0.001), one of the key chemokines that regulate migration and infiltration of monocytes/macrophages.
Glutamate (↑GLU)
Glutamate is the brain's principal excitatory neurotransmitter, and excessive activation of N-methyl-D-aspartate receptors may lead to neuronal degeneration and cell death.
Excess excitotoxicity resulting from glutamate hypertransmission is one of the proposed theories to explain the abnormal neuronal responses to acute medical insults, such as delirium. Animal models have found that cerebral ischemia may be associated with an up to 7-fold increase in extracellular GLU levels, significantly correlated with infarct size. Studies have suggested that the neurotoxicity of beta-amyloid peptide may be related to the overactivation of glutamatergic transmission and excitotoxicity, which may serve as a potential explanation to the increased rate of delirium in patients with baseline cognitive dysfunction and may further explain the long-term cognitive impairment following episodes of delirium. The mechanisms mediating the dramatic rise in GLU levels among delirious patients have been reviewed elsewhere. Glutamate's and DA's actions are interdependent, as it appears that GLU requires the presence of DA to exert some of its toxic effects, namely, Ca Serotonin (↓↑5HT) Both elevation and deficiencies in 5-hydroxytryptamine (serotonin; 5HT) activity have been linked to the development of delirium. Normal 5HT synthesis and release in the brain are dependent on the availability of its precursor tryptophan (TRP). Please see Figure 13 for a relationship between TRP, 5HT, and kynurenic acid metabolism. Reduced 5HT levels have been identified in patients suffering from delirium associated with AWS, catabolic states, hypoxia, immobility, infections, ischemia, and postoperative states among others. In fact, the sudden discontinuation of 5HT reuptake inhibitors has been associated with various neuropsychiatric syndromes, including delirium. Similarly, decreased TRP availability may lead to a reduction in 5HT. All large neutral amino acids (LNAA; ie, phenylalanine [PHE], TRP, leucine, isoleucine, methionine, tyrosine, and valine) compete to enter the brain through the same saturable carrier. Therefore, as the concentration of one increases, central nervous system entry of other LNAAs conversely decreases. Phenylalanine has the additional interesting property of conversion to neurotoxic metabolites and competes with TRP for entry into the brain. Once it enters the brain, PHE competes with TRP and tyrosine for metabolism, via hydroxylation. Studies have demonstrated that elevations of the PHE/ LNAA ratio are independently associated with POD. Studies of older medically ill patients suggest that an elevated plasma PHE/LNAA ratio during acute febrile illness is associated with delirium. Patients with hepatic and septic encephalopathy have also been found to experience increased levels of PHE and PHE metabolites in the plasma and cerebrospinal fluid. Similarly, hepatic dysfunction may lead to decreased metabolism of precursor amino acids (ie, PHE and tyrosine), which may lead to increases in TRP availability, which leads to increases in 5HT. In fact, elevation in 5-hydroxyindoleacetic acid levels has been associated with HE and in patients suffering from hypoactive delirium. Studies have found that an increased ratio of free to bound TRP enhances its availability to brain tissue, which in turn increases 5HT synthesis, thus precipitating HE. Conversely, elevated 5HT levels have been described among patients suffering from delirium associated with clozapine toxicity, HE, and 5HT syndrome. In fact, in a recent study of delirium in the intensive care unit, investigators found that 72% of those experiencing delirium were receiving drugs potentially contributing to serotonergic toxicity. Some have reported that the stereotactic injection of WAY-100635, a 5HT-1A antagonist, improved the delirium-like behavior in animal models; and at least 3 reports have suggested that selective 5HT 5HT3-type receptor antagonists may be effective in the treatment of agitated POD.
Histamine (↓↑H1&2) There is evidence suggesting that both increased and decreased histamine (HA) levels may lead to delirium. Histamine receptors A1 (HA1) and A2 (HA2) are known to affect the polarity of cortical and hippocampal neurons and that it is well known that pharmacological antagonism of either receptor is sufficient to cause delirium. Clinical data have demonstrated that the use of H1 blockers (eg, diphenhydramine and promethazine) and H2 blockers has been associated with a significant increase in the occurrence of delirium, especially among older adults and those with chronic kidney disease. Excessive release of HA, like during surgical stress and hypoxia, may lead to delirium, with data suggesting that the first-generation anti-HA agent cyproheptadine can be a potential option for the prevention of POD.
Gamma-aminobutyric acid (↓↑GABA) γ-Aminobutyric acid (GABA) is the brain's principal inhibitory neurotransmitter and plays a role in regulating neuronal excitability throughout the nervous system. Evidence suggests that GABA activity is increased in some types of delirium (eg, cerebral ischemia and HE), while decreased in others (eg, antibiotic-induced delirium and alcohol or central nervous system depressant withdrawal). The mechanisms mediating GABAergic agents' deliriogenic effects have been reviewed elsewhere. 26 Evidence also suggests that endogenous GABA causes tonic inhibition of ACh release in the ventral hippocampus via septal GABA(A) receptors and, to a lesser extent, via GABA(B) receptors in the medial septum and hippocampus. A systematic review including 68 drug trials found that benzodiazepine drugs consistently induced both amnestic and nonamnestic cognitive impairments, with evidence of a dose-response relationship.
primarily the prefrontal cortex. 172 With advanced age, there is a downregulation of several subunits of the GABA A receptors (ie, α1, α5, β3, and γ2); therefore, a stimulus that increases the level of inhibitory tone may have a greater effect and further break down network connectivity. 173 The aged brain also experiences reductions in orexin signaling, 174, 175 which may contribute to the fluctuating arousal level seen in delirious states when exposed to various noxious stimuli (eg, infection, GABAergic agents, and sleep deprivation). Similarly, it intersects with the NTH as it specifically implicates the GABA system (eg, benzodiazepine or hepatic encephalopathy-induced delirium) and the cholinergic system (eg, anticholinergic delirium) as likely principal culprits.
| DELIRIUM AS A FAILURE OF CNS SYSTEM INTEGRATION: TOWARDS A UNIFYING HYPOTHESIS OF DELIRIUM
The systems integration failure hypothesis (SIFH) brings together the most salient, previously described theories contributing to the development of delirium into one cohesive paradigm (Figure 17 ), Thus, the SIFH suggests that at any given time, a number of precipitant factors may serve as triggers for the development of delirium or acute brain failure. The mnemonic "end acute brain failure" (see Table 1 ) summarizes the set of precipitant insults long recognized as acute proximate factors to the development of delirium. and GABAergic pathways, as well as multiple critical cerebral systems FIGURE 15 Network disconnectivity hypothesis of delirium. Activity of the seed region in comparison subjects showed positive correlations (red) with the posteromedial/anteromedial cortices and the temporoparietal junctions and a negative correlation (blue) with the frontolateral cortices. These correlations disappeared in the anteromedial and cortices and were enhanced in the posteromedial cortices during an episode of delirium. Source: Choi et al 146 [Colour figure can be viewed at wileyonlinelibrary.com] FIGURE 16 Network influencing alertness vs somnolence. Relationship between acetylcholine (ACh; necessary for the initiation of rapid eye movement [REM] sleep), noradrenaline (NA; its activity in the locus coeruleus [LC; the main is involved in arousal] is the most important regarding the sleep-wake cycle), dopamine (DA; seems to regulate sleep-wake states and helps control when we enter each and can also can downregulate melatonin), melatonin (MEL; helps regulate circadian rhythms in the body as a reaction to environmental lighting conditions), 5-hydroxytryptamine (5HT; helps to maintain arousal and cortical responsiveness as well as inhibit REM sleep), and orexin (OX, hypocretin; produced in the hypothalamus and is responsible for regulating many different systems involved with sleep and stabilizing both awake and sleep states). The OX system regulates DA, NA, histamine (HA), and ACh systems. It is also responsible for integrating different metabolic demands, circadian rhythms, and sleep debt to decide what state the body should be in (asleep or awake); GABA, the main inhibitory neurotransmitter (NT), induces sleep by downregulating activity in the posterior hypothalamus (thus inducing sleep). Glutamate, the primary excitatory NT, is also the most common NT in the brain. Glutamatergic inputs in the posterior hypothalamic region help regulate both REM sleep and wakefulness. Source: A, Scammell and Saper 159 ; B, Brown et al 160 [Colour figure can be viewed at wileyonlinelibrary.com] including the striatum, the substantia nigra/ventral tegmental area, and the thalamus. The thalamus acts as a filter, allowing only the relevant information to travel to the cortex. It is here that we find the significant role of the cortical cholinergic system and associated projections in mediating specific attentional processing (ie, sustained, selective, and divided attention performance), arousal, and rapid eye movement sleep-associated dreaming. 176, 177 Under normal circumstances, cholinergic activity in the prefrontal regions facilitates the activation of the anterior attention system and associated executive functions. 176 Besides deficits in ACh and excess of GLU, NE, and DA, other neurotransmitter systems may also be involved, adding to the phenotypic presentation and pattern of behavior and cognitive deficits.
According to the SIFH, there are multiple important determinants that eventually predict a subject's vulnerability to delirium: (a) the presence of physiological vulnerabilities (the substrate) and (b) an acute insult (precipitant) further taxing an already fragile system with limited functional reserves. The various vulnerabilities make it more likely that a patient may experience a derangement in functional metabolism leading to (c) an alteration in neurotransmitter synthesis, function, and/or availability and (d) a dysregulation of neuronal activity and connectivity secondary to systemic disturbances, which mediates the complex phenotypic and neurocognitive changes observed in delirium (see Figures 13 and 17 ; Table 7 ).
The interplay between the alterations in neurotransmitter integrity (ie, neurotransmitter availability and receptor function) and which network emerges as dominant or unchecked and the variability in integration and appropriate processing of sensory information and motor responses, mediated by an acute breakdown in brain network connectivity, give rise to the various clinical manifestations observed in the various delirial motoric phenotypes (eg, hyperactive, hypoactive, and mixed). In other words, the form of delirium that ensues will depend upon how and which networks break down, influenced by both the individual's baseline network connectivity and the degree change in inhibitory tone produced (see Figures 16 and 17) .
Furthermore, the SFIH suggests that the lack of systems integration and alteration in neurotransmitter homeostasis leads to the aberrant activation of parasympathetic control, triggered by a number of physiological signals associated with illness processes (eg, mechanical ventilation), leading to pathological signaling activation of neuroreceptors, which ultimately triggers apoptosis in various brain areas, independent of hypoxia, oxidative stress, or inflammatory responses. Ultimately, this aberrant signaling can trigger both early and late apoptotic triggers, which may mediate both the acute changes classically associated with acute delirium, as well as the more prolonged cognitive changes we associated with persistent delirium. Thus, the SIFH suggests that the various phenotypic presentations of delirium (eg, hypoactive, hyperactive, mixed, or subsyndromal) may be better explained by the action of various factors acting on specific brain neurochemical systems, 178 placing an already fragile and disconnected system at risk of malfunction, thus leading to the symptoms of acute brain failure.
| CONCLUSIONS
Delirium is a neurobehavioral syndrome caused by the transient disruption of normal neuronal activity, mediated by alterations in the neurotransmitter and dysfunction of neuronal networks, secondary to systemic disturbances. The combined effect of precipitant and substrate factors leads to final common pathways associated with the behavioral and cognitive changes observed in delirium, including the various phenotypic presentations.
The SIFH integrates and explains how the most salient etiological theories converge into an integrated web of pathways-highlighting A better understanding of the underlying pathophysiology may eventually assist us in designing better delirium prevention and management approaches.
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